HUE063939T2 - Bio-reszorbeálható poliésztert, hidrofil polimert és acilált humán laktoferrin-eredetû peptidet tartalmazó nanorészecske - Google Patents
Bio-reszorbeálható poliésztert, hidrofil polimert és acilált humán laktoferrin-eredetû peptidet tartalmazó nanorészecskeInfo
- Publication number
- HUE063939T2 HUE063939T2 HUE19720106A HUE19720106A HUE063939T2 HU E063939 T2 HUE063939 T2 HU E063939T2 HU E19720106 A HUE19720106 A HU E19720106A HU E19720106 A HUE19720106 A HU E19720106A HU E063939 T2 HUE063939 T2 HU E063939T2
- Authority
- HU
- Hungary
- Prior art keywords
- nanoparticle
- bio
- hydrophilic polymer
- derived peptide
- human lactoferrin
- Prior art date
Links
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 title 1
- 102000050459 human LTF Human genes 0.000 title 1
- 229920001477 hydrophilic polymer Polymers 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 229920000728 polyester Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polyesters Or Polycarbonates (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18171195 | 2018-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE063939T2 true HUE063939T2 (hu) | 2024-02-28 |
Family
ID=62142979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE19720106A HUE063939T2 (hu) | 2018-05-08 | 2019-04-24 | Bio-reszorbeálható poliésztert, hidrofil polimert és acilált humán laktoferrin-eredetû peptidet tartalmazó nanorészecske |
Country Status (14)
Country | Link |
---|---|
US (1) | US11052053B2 (hu) |
EP (1) | EP3790534B1 (hu) |
JP (1) | JP2021523137A (hu) |
KR (1) | KR20210008496A (hu) |
CN (1) | CN112469397B (hu) |
BR (1) | BR112020022353A2 (hu) |
CA (1) | CA3099459A1 (hu) |
ES (1) | ES2964393T3 (hu) |
HU (1) | HUE063939T2 (hu) |
IL (1) | IL278469B2 (hu) |
MX (1) | MX2020011724A (hu) |
PL (1) | PL3790534T3 (hu) |
SI (1) | SI3790534T1 (hu) |
WO (1) | WO2019214939A1 (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2973827T3 (es) | 2019-10-31 | 2024-06-24 | Evonik Operations Gmbh | Proceso de preparación de nano- o micropartículas que comprenden un polímero portador y uno o más principios biológicamente activos |
CN111393227B (zh) * | 2020-04-08 | 2022-07-08 | 黑龙江八一农垦大学 | 一种种衣剂 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3937272A1 (de) | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Neue copolymere aus trimethylencarbonat und optisch inaktiven laktiden |
DE10200738A1 (de) | 2002-01-11 | 2003-08-07 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von resorbierbaren Polyestern durch Massepolymerisation |
US6706854B2 (en) | 2002-01-11 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for preparing reabsorbable polyesters by mass polymerization |
DE102005033101A1 (de) | 2005-07-15 | 2007-01-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten |
DE102005051366A1 (de) * | 2005-10-25 | 2007-04-26 | Degussa Gmbh | Drug Delivery Systeme |
WO2007076904A1 (en) | 2005-12-30 | 2007-07-12 | Evonik Röhm Gmbh | Peptides useful as cell-penetrating peptides |
DE102007020951A1 (de) | 2007-05-04 | 2008-11-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren und Vorrichtung zur Reinigung eines resorbierbaren Polyesters |
CN103906760B (zh) | 2010-11-26 | 2017-02-22 | 赢创罗姆有限公司 | 用作抗原掩蔽剂的人乳铁蛋白衍生肽 |
US11090366B2 (en) * | 2011-10-31 | 2021-08-17 | Kane Biotech Inc. | Compositions and methods for reducing oral biofilm |
US9770419B2 (en) * | 2012-08-01 | 2017-09-26 | Shaker A. Mousa | Methods and compositions of camel derived products |
JP6588039B2 (ja) * | 2014-05-28 | 2019-10-09 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH | ナノ粒子 |
-
2019
- 2019-04-24 IL IL278469A patent/IL278469B2/en unknown
- 2019-04-24 US US17/052,947 patent/US11052053B2/en active Active
- 2019-04-24 SI SI201930646T patent/SI3790534T1/sl unknown
- 2019-04-24 CA CA3099459A patent/CA3099459A1/en active Pending
- 2019-04-24 KR KR1020207034971A patent/KR20210008496A/ko not_active Application Discontinuation
- 2019-04-24 ES ES19720106T patent/ES2964393T3/es active Active
- 2019-04-24 HU HUE19720106A patent/HUE063939T2/hu unknown
- 2019-04-24 CN CN201980030692.5A patent/CN112469397B/zh active Active
- 2019-04-24 WO PCT/EP2019/060410 patent/WO2019214939A1/en unknown
- 2019-04-24 EP EP19720106.4A patent/EP3790534B1/en active Active
- 2019-04-24 BR BR112020022353-0A patent/BR112020022353A2/pt not_active Application Discontinuation
- 2019-04-24 PL PL19720106.4T patent/PL3790534T3/pl unknown
- 2019-04-24 MX MX2020011724A patent/MX2020011724A/es unknown
- 2019-04-24 JP JP2020562591A patent/JP2021523137A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PL3790534T3 (pl) | 2024-02-19 |
CN112469397B (zh) | 2022-12-02 |
EP3790534A1 (en) | 2021-03-17 |
IL278469B2 (en) | 2024-02-01 |
US20210137847A1 (en) | 2021-05-13 |
ES2964393T3 (es) | 2024-04-05 |
WO2019214939A1 (en) | 2019-11-14 |
EP3790534B1 (en) | 2023-08-30 |
CN112469397A (zh) | 2021-03-09 |
SI3790534T1 (sl) | 2023-12-29 |
BR112020022353A2 (pt) | 2021-02-02 |
JP2021523137A (ja) | 2021-09-02 |
US11052053B2 (en) | 2021-07-06 |
IL278469B1 (en) | 2023-10-01 |
CA3099459A1 (en) | 2019-11-14 |
KR20210008496A (ko) | 2021-01-22 |
IL278469A (hu) | 2021-01-31 |
MX2020011724A (es) | 2021-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276549A (en) | CAMK2D antisense oligonucleotides and their uses | |
HK1256995A1 (zh) | 藥物輸送設備、系統和方法中的阻塞解決方案 | |
EP3664696C0 (en) | PATIENT MOVEMENT AND INCONTINENCE NOTIFICATION SYSTEM | |
IL284835A (en) | Pharmaceutical combination containing TNO155 and ribociclib | |
EP3505543A4 (en) | HYDROPHILIC COPOLYMER AND MEDICAL DEVICE | |
EP3622407A4 (en) | PATIENT TREATMENT SYSTEMS AND METHODS | |
IL289374A (en) | Methods and systems for providing an ocular device | |
EP3661455A4 (en) | HAIR IMPLANTS WITH IMPROVED ANCHORING AND MEDICAL SAFETY FEATURES | |
GB201701867D0 (en) | Controlled and verifiable information destruction | |
EP3493749A4 (en) | SPIRAL TISSUE ANCHOR AND RELEASE SYSTEM | |
SI3790534T1 (sl) | Nanodelec, ki vsebuje bioresorbirni poliester, hidrofilni polimer in aciliran peptid, pridobljen iz človeškega laktoferina | |
EP3568191A4 (en) | MEDICAL INFLATION SYSTEMS AND PROCEDURES | |
EP3407804A4 (en) | SYSTEMS AND METHOD FOR THE ADMINISTRATION OF A GASTROINTESTINAL IMPLANT | |
SG11202008177WA (en) | Compstatin analogues and their medical uses | |
IL290858A (en) | Compstatin analogs and their medical uses | |
GB2587252B (en) | Antenna, implantable medical device, and implantable medical system | |
IL273713A (en) | Drug administration systems and related methods | |
EP3607887A4 (en) | OCCLUDE AND OCCLUSION DEVICE | |
EP3626155C0 (en) | ENDOSCOPIC SYSTEM COMPRISING AN ENDOSCOPIC DEVICE AND A DEVICE FOR ESTIMATING THE SHAPE OF THE FLEXIBLE PARTS | |
EP3744264C0 (en) | OCCLUDER AND MEDICAL DEVICE | |
EP3706771A4 (en) | BCL9 PEPTIDES AND VARIANTS THEREOF | |
EP3664856A4 (en) | POLY (ESTER-UREA) FOR MEMORY AND DRUG ADMINISTRATION | |
EP3398981A4 (en) | HYDROPHILIC POLYESTER AND BLOCK COPOLYMER COMPRISING SAME | |
EP3409677A4 (en) | MODIFIER INITIATOR AND MODIFIED CONJUGATED DIENE POLYMER COMPRISING THE SAME | |
EP3982841A4 (en) | DIRECTIONAL INTRACRANIAL OCCLUSION DEVICE AND METHOD |